Evaluation of Food Effect on the Oral Absorption of Clarithromycin from Immediate Release Tablet using Physiological Modelling

Evaluation of Food Effect on the Oral Absorption of Clarithromycin from Immediate Release Tablet using Physiological Modelling

Publication: Biopharm Drug Dispos
Software: GastroPlus®

The aim of the present study was to investigate the influence of food on the oral absorption of Clarithromycin by evaluating the effect of media parameters such as; pH, bile secretions and food composition on...

A physiologically based pharmacokinetic (PBPK) modeling of amlodipine: High enterocyte binding, not enterohepatic circulation, is responsible for the long Tmax

A physiologically based pharmacokinetic (PBPK) modeling of amlodipine: High enterocyte binding, not enterohepatic circulation, is responsible for the long Tmax

Conference: ASCPT
Software: GastroPlus®
Division: PBPK

Amlodipine is a second generation calcium channel blocker that has been widely used in the therapy of hypertension and angina pectoris.

In Silico Screening to Identify Inhibitors of Growth Factor Receptor 2–Focal Adhesion Kinase Interaction for Therapeutic Treatment of Pathological Cardiac Hypertrophy

In Silico Screening to Identify Inhibitors of Growth Factor Receptor 2–Focal Adhesion Kinase Interaction for Therapeutic Treatment of Pathological Cardiac Hypertrophy

Publication: Assay Drug Dev Technol

The focal adhesion kinase–growth factor receptor 2 (FAK–Grb2) protein–protein interaction is implicated in pathogenesis of stress-induced cardiac hypertrophy.

A Simulation and Estimation Platform for Malaria Model Evaluation

A Simulation and Estimation Platform for Malaria Model Evaluation

Conference: ASCPT
Software: KIWI™

Accelerating clinical development of new compounds demands efficient systems for evaluation and interpretation of trial results. Systematizing trial evaluation methods yields efficiency and confidence in results.

Developing PBPK for Ocular Delivery

Developing PBPK for Ocular Delivery

Authors: Bolger MB
Conference: ASCPT
Software: GastroPlus®
Division: PBPK

Cooperation grant with the FDA (2014‐2019) a 4‐year funded collaborative project with the FDA  Office of Generic Drugs on the development of  mechanistic models for ocular delivery

Assessing Effects of Sublingual BHV-0223 and Oral Riluzole on Liver Function Test Parameters

Assessing Effects of Sublingual BHV-0223 and Oral Riluzole on Liver Function Test Parameters

Authors: Howell BA
Conference: SOT
Software: DILIsym®

DILIsym is a mechanistic, mathematical model that has been constructed to support pharmaceutical risk assessment and decision making

Pharmacokinetics, Pharmacodynamics, and PKPD Modeling of Curcumin in Regulating Antioxidant and Epigenetic Gene Expression in Healthy Human Volunteers

Pharmacokinetics, Pharmacodynamics, and PKPD Modeling of Curcumin in Regulating Antioxidant and Epigenetic Gene Expression in Healthy Human Volunteers

Publication: Mol Pharm
Software: ADMET Predictor®

Curcumin is a major component of the spice turmeric (Curcuma longa), often used in food or as a dietary supplement. Many preclinical studies on curcumin suggest health benefits in many diseases due to its antioxidant/anti-inflammatory and epigenetic effects.

Development of a Quantitative Systems Toxicology Model of Drug-Induced Cholangiocyte Injury in DILIsym

Development of a Quantitative Systems Toxicology Model of Drug-Induced Cholangiocyte Injury in DILIsym

Conference: SOT
Software: DILIsym®

Cholangiocyte injury accounts for a quarter of drug-induced liver injury (DILI) cases and is associated with higher rates of morbidity and mortality than hepatocellular DILI (Chalasani et al., 2015).

Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications

Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications

Publication: Eur J Pharm Biopharm
Software: GastroPlus®

Enteric coatings have shown in vivo dissolution rates that are poorly predicted by traditional in vitro tests, with the in vivo dissolution being considerably slower than in vitro.

Building a Quantitative Structure-Property Relationship (QSPR) Model

Building a Quantitative Structure-Property Relationship (QSPR) Model

Authors: Clark RD, Daga PR
Publication: Bioinformatics and Drug Discovery
Software: ADMET Predictor®
Division: PBPK

Knowing the physicochemical and general biochemical properties of a compound is critical to understanding how it behaves in different biological environments and to anticipating what is likely to happen in situations where that behavior cannot be measured directly.

In silico resources to assist in the development and evaluation of physiologically-based kinetic models

In silico resources to assist in the development and evaluation of physiologically-based kinetic models

Publication: Computational Toxicology

Since their inception in pharmaceutical applications, physiologically-based kinetic (PBK) models are increasingly being used across a range of sectors, such as safety assessment of cosmetics, food additives, consumer goods...

Radiosynthesis and in vivo evaluation of 11C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptors

Radiosynthesis and in vivo evaluation of 11C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptors

Publication: EJNMMI Radiopharm Chem
Software: ADMET Predictor®

Neuropeptide Y (NPY) has been implicated in a wide variety of physiological processes, including feeding, learning, memory, emotion, cardiovascular homeostasis, hormone secretion, and circadian rhythms.

The DILI‐sim Initiative: Insights into Hepatotoxicity Mechanisms and Biomarker Interpretation

The DILI‐sim Initiative: Insights into Hepatotoxicity Mechanisms and Biomarker Interpretation

Authors: Watkins PB
Publication: Clin Transl Sci
Software: DILIsym®

The drug‐induced liver injury (DILI)‐sim Initiative is a public‐private partnership involving scientists from industry, academia, and the US Food and Drug Administration (FDA).

Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link-a Workshop Summary Report

Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link-a Workshop Summary Report

Publication: AAPS J

This publication summarizes the proceedings of day 2 of a 3-day workshop on “Dissolution and Translational Modeling Strategies Enabling Patient-Centric Product Development."